4D pharma hails 'very promising' clinical results for cancer treatment
Pharmaceutical company 4D pharma hailed 'very promising' results from the clinical trial for its biotherapeutic candidate MRx0518 in combination with MSD's immune checkpoint inhibitor, Keytruda,...
Wed, 26/08/2020 - 08:43